Category: phthalazine

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 763114-26-7, name is 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid, introducing its new discovery. 763114-26-7

A micro-channel modular reaction device for continuously preparing aurar handkerchief nepal intermediates (by machine translation)

The present invention discloses a micro-channel aurar handkerchief nepal modular reaction device for the continuous production of the intermediates, including 3 – hydroxy isobenzofuran – 1 (3 H) – ketone and dimethyl methylene chloride solution of dichloromethane solution in the micro-reactor in the 1st reaction, liquid obtained by (3 – oxo – 1, 3 – ISO-benzofuran – 1 – yl) dimethyl phosphate effluent; then with 2 – fluoro – 5 – formyl phenyl nitrile dichloromethane solution of triethylamine in methylene chloride solution and 2nd micro-reactor to react to generate 2 – fluoro – 5 – (3 – oxo – 3 H – isobenzofuran – 1 – yl methylene) reaction of the nitrile; finally the reaction liquid with the ethanol solution of sodium hydroxide is obtained by stirring with hydrazine hydrate of homogeneous mixed solution in the micro-reactor in the 3rd reaction, processing effluent to obtain the aurar handkerchief nepal intermediate 2 – fluoro – 5 – [(4 – oxo – 3, 4 – dihydrodi diazonaphthalene – 1 – yl) methyl] benzoic acid. (by machine translation)

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.763114-26-7, you can also check out more blogs about763114-26-7

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N743 – PubChem

72702-95-5, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 72702-95-5, Name is 2-(3-(4-Bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid, molecular formula is C17H12BrFN2O3. In a Article, authors is Poulsom£¬once mentioned of 72702-95-5

Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type

Aldose reductase (EC 1.1.1.21) was purified approximately 5000-fold from bovine lens by ammonium sulphate fractionation and chromatography on DEAE-Sephacel and Matrex OA. Inhibition of this enzyme was found to depend upon the assay substrate. Tested against the purest form of enzyme, the inhibitor Sorbinil gave IC50 values of approximately 100 muM with the model substrate 4-nitrobenzaldehyde (4NB) and 0.4-1.4 muM with the physiological substrate glucose. A similar effect of substrate was found for the inhibitor Statil (IC50 450-750 nM with 4NB, 26-71 nM with glucose substrate). The implications of these results towards the assessment of aldose reductase inhibitors in vitro are discussed.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.72702-95-5. In my other articles, you can also check out more blogs about 72702-95-5

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N906 – PubChem

72702-95-5, In an article, published in an article,authors is Cavallo, Gabriella, once mentioned the application of 72702-95-5, Name is 2-(3-(4-Bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid,molecular formula is C17H12BrFN2O3, is a conventional compound. this article was the specific content is as follows.

The halogen bond

The halogen bond occurs when there is evidence of a net attractive interaction between an electrophilic region associated with a halogen atom in a molecular entity and a nucleophilic region in another, or the same, molecular entity. In this fairly extensive review, after a brief history of the interaction, we will provide the reader with a snapshot of where the research on the halogen bond is now, and, perhaps, where it is going. The specific advantages brought up by a design based on the use of the halogen bond will be demonstrated in quite different fields spanning from material sciences to biomolecular recognition and drug design.

72702-95-5, Interested yet? Read on for other articles about 72702-95-5!

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N853 – PubChem

763114-26-7, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 763114-26-7, name is 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid, introducing its new discovery.

PARP – 1 and Tankyrase1/2 multi-target inhibitor, its preparation and its use (by machine translation)

The invention relates to the field of pharmaceutical chemistry, in particular relates to a containing phthalazine – 1 (2 H) – one structure of PARP – 1 and tankyrase1/2 multi-target inhibitor (I), processes for their preparation, and pharmaceutical compositions containing these compounds and their use of anti-tumor. (by machine translation)

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.763114-26-7, you can also check out more blogs about763114-26-7

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N781 – PubChem

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.253-52-1, Name is Phthalazine, molecular formula is C8H6N2, 253-52-1. In a Article, authors is Stefaniak, L.£¬once mentioned of 253-52-1

15N NMR Spectroscopy of Some Azines

15N NMR shielding data are presented for 56 cyclic azines in 0.5 M dimethyl sulfoxide solutions with 0.01 M increments of Cr(acac)3 added for each nitrogen atom in the molecules.For the polyazines, the 15N signal assignments were based on 2J(NH) interactions and some INDO/S-SOS shielding calculations.The effects of alpha-, beta- and gamma-methyl and conjugated ring substitution on nitrogen shielding are presented and discussed, as are the influences arising from fusion with alicyclic and aromatic rings at various positions.The effects of a second nitrogen atom on the shielding of the first one are shown to be critically dependent on both their relative positions and on the position of fusion of conjugated ring systems.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.253-52-1. In my other articles, you can also check out more blogs about 253-52-1

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N420 – PubChem

253-52-1, An article , which mentions 253-52-1, molecular formula is C8H6N2. The compound – Phthalazine played an important role in people’s production and life.

Aldehyde oxidase at the crossroad of metabolism and preclinical screening

Human AOX1 is a member of the mammalian aldehyde oxidase (AOX) family of enzymes and it is an emerging cytosolic enzyme involved in phase I drug-metabolism, bio-transforming a number of therapeutic agents and xenobiotics. The current trend in drug-development is to design molecules which are not recognized and inactivated by CYP450 monooxygenases, the main drug-metabolizing system, to generate novel therapeutic agents characterized by optimal pharmacokinetic and pharmacodynamic properties. Unfortunately, this has resulted in a substantial enrichment in molecules which are recognized and metabolized by AOXs. The observation has raised interest in the generation of tools capable of predicting AOX-dependent drug-metabolism of novel molecules during the early phases of drug development. Such tools are likely to reduce the number of failures occurring at the clinical and late phase of the drug development process. The current review describes different in silico, in vitro and in vivo methods for the prediction of AOX metabolizing ability and focuses on the existing drawbacks and challenges associated with these approaches.

253-52-1, Interested yet? Read on for other articles about 253-52-1!

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N109 – PubChem

253-52-1, One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, such as the rate of change in the concentration of reactants or products with time.In a article, authors is Magriz, Antonio, mentioned the application of 253-52-1, Name is Phthalazine, molecular formula is C8H6N2

Phthalazin-2-ylidenes as cyclic amino aryl carbene ligands in rhodium(I) and iridium(I) complexes

The direct metalation of phthalazinium halides with [Rh( tBuO)(COD)]2 or [Ir(tBuO)(COD)]2 led to the isolation of stable [MCl(phthalazin-2-ylidene)X(COD)] (M = Rh, Ir) as a new family of cyclic amino aryl carbene transition metal complexes. The X-ray diffraction analysis of several representatives systematically revealed a relatively short C(aryl)-C(carbene) bond distance of 1.44-1.46 A, shorter than the typical C(sp2)-C(sp2) single bond, indicating some electron density delocalization from the pi system of the aryl ring over the vacant carbene orbital.

253-52-1, Interested yet? Read on for other articles about 253-52-1!

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N275 – PubChem

Because a catalyst decreases the height of the energy barrier, 253-52-1, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.253-52-1, Name is Phthalazine, molecular formula is C8H6N2. In a article£¬once mentioned of 253-52-1

On the Synthesis of Zwitterionic Heteropolycyclic Pyrazoles by a Three-Component Reaction. Some Mechanistic Considerations

The novel three-component reaction involving a heterocyclic iminophosphorane, an isocyanate, and a hetarene component is applied to an aromatic pyrazole iminophosphorane 1 and to an analogous pyrazolone derivative 13.The hitherto unknown zwitterionic pyrazolo<3',4':4,5>pyrimido<6,1-a>isoquinolines 11a,b and 16a,b, pyrazolo<3',4':4,5>pyrimido<6,1-a>phthalazine 6b, and pyrazolo<3',4':4,5>pyrido<6,1-a>pyrimidines 15a,b are obtained.Additionally, the novel cycloaddition products with triazolinediones, the pyrazolo<3,4-e><1,2,4>triazolo<1,2-a><1,2,4>triazinediones 9a,b are described.The isolation of the dihydro compound 4 and the phthalazinium salt 5 supports a stepwise mechanism for the zwitterion formation.While the influence of the aromaticity of the iminophosphorane component appears to be negligible, the aromaticity of the hetarene component determines the limitations of this versatile reaction.X-ray structures of 11a, 5b, and 16b as well as UV-, MS-, and NMR-spectra and semiempirical calculations confirm the zwitterionic character of the reaction products.

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. 253-52-1, In my other articles, you can also check out more blogs about 253-52-1

Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N465 – PubChem

19064-74-5, We know that the rate of many reactions can be accelerated by catalysts. A catalyst speeds up the rate of a reaction by lowering the activation energy; in addition, the catalyst is regenerated in the process. 6-Bromophthalazine, cas is 19064-74-5,the phthalazine compound, below Introduce a new synthetic route.

A mixture of 6-bromophthalazine (0.11 g, 0.50 mmol), 6-chloro-N-methyi-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine (0.16 g, 0.58 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2’bi(1 ,3,2-dioxaborolane) (0.14 g, 0.55 mmol), potassium acetate (0.15 g, 1.5 mmol) and [1, 1 ‘bis(diphenylphosphino)ferrocene]dichloropalladium(ll), complex with dichloromethane (0.04 g, 0.05mmol) in dioxane (3 ml) was heated at 80 oc for 3 h. Potassium carbonate (0.20 g, 1.5 mmol) and10 water (0.4 ml) were added and the mixture was stirred for 48 hat 90 C. After cooling, the reactionwas purified by solid phase extraction (SiliaBond Carbonate, MeOH as eluent). After evaporationof the solvent under reduced pressure, the material afforded was purified via reverse phasepreparative HPLC using 5 to 95% acetonitrile in water modified with 3% n-PrOH. LCMS: Rt = 0.43min [M+H] (LCMS method Q); 377.245; 1H NMR (400 MHz, DMSO-d6) o 9.74-9.62 (m, 2H), 8.7515 (s, 1H), 8.74 (dd, J= 8.5, 2.0 Hz, 1H), 8.23 (d, J= 8.5 Hz, 1H), 8.12 (d, J= 9.5 Hz, 1H), 7.19 (d, J=9.5 Hz, 1H), 5.19 (tt, J= 12.0, 3.5 Hz, 1H), 2.98 (s, 3H), 1.56 (dd, J= 12.0, 3.5 Hz, 2H), 1.45 (t, J=12.0 Hz, 2H), 1.27 (s, 6H), 1.10 (s, 6H).

Any one of these steps may be slow and thus may serve as the rate determining step. In general, however, in the presence of the catalyst, the overall rate of the reaction is faster than it would be if the reactants were in the gas or liquid phase., 19064-74-5

Reference£º
Patent; NOVARTIS AG; CHEUNG, Atwood; CHIN, Donovan Noel; DALES, Natalie; FAZAL, Aleem; HURLEY, Timothy Brian; KERRIGAN, John; O’BRIEN, Gary; SHU, Lei; SUN, Robert; SUNG, Moo; WO2014/28459; (2014); A1;,
Phthalazine – Wikipedia
Phthalazine | C8H6N2 – PubChem

A balanced equation for a chemical reaction indicates what is reacting and what is produced, 1242156-59-7, but it reveals nothing about how the reaction actually takes place. The reaction mechanism is the process, or pathway, by which a reaction occurs.6-(tert-Butyl)-8-fluorophthalazin-1(2H)-one, cas is 1242156-59-7,the phthalazine compound. An updated downstream synthesis route of 1242156-59-7 as follows.

Step 5. Preparation of 2-(6-tert-butyl-8-fluoro-l-oxo-lH-phthalazin-2-yl)-4-iodo-pyridine-3- carbaldehyde Method A In a 1 L round-bottomed flask, 6-tert-butyl-8-fluorophthalazin-l(2H)-one (5.6 g, 25.4 mmol) was combined with THF (300 ml) to give a colorless solution. Sodium hydride (1.12 g, 28.0 mmol) was added. The reaction mixture was stirred at ambient temperature for 10 min. 2-Fluoro-4- iodonicotinaldehyde (7.02 g, 28.0 mmol) was added and the reaction mixture was stirred at ambient temperature for 1 h. The reaction was complete as determined by LCMS analysis. The reaction mixture was quenched with saturated NH4CI. The reaction mixture was poured into 200 mL of H20 and extracted thrice with CH2CI2. The organic layers were washed with brine, then dried over Na2S04 and concentrated under vacuum. The resultant bright yellow solid was transferred into a filter funnel and the flask washed twice with a small volume of EtOAc to ensure complete transfer of the solid into the funnel. The liquid was filtered through. The solid was triturated twice with Et20 and dried under vacuum to afford the desired product as a cream- colored solid (8.09 g, 17.9 mmol, 70.5 % yield). (M+H)+ = 452 m/e. *H NMR (400 MHz, CUC -d) delta ppm 1.44 (s, 9 H) 7.49 – 7.54 (m, 1 H) 7.54 (d, 7=1.77 Hz, 1 H) 8.03 (d, 7=5.31 Hz, 1 H) 8.30 (d, 7=2.53 Hz, 1 H) 8.37 (d, 7=5.31 Hz, 1 H) 9.98 (s, 1 H).

Chemical properties determine the actual use. Each compound has specific chemical properties and uses. We look forward to more synthetic routes in the future to expand reaction routes of 6-(tert-Butyl)-8-fluorophthalazin-1(2H)-one, 1242156-59-7

Reference£º
Patent; F. HOFFMANN-LA ROCHE AG; HOFFMANN-LA ROCHE INC.; IYER, Raman Mahadevan; LAINE, Dramane Ibrahim; LOPEZ-TAPIA, Francisco Javier; PHILLIPS, Jonathan E.; STEVENSON, Christopher; WO2014/83026; (2014); A1;,
Phthalazine – Wikipedia
Phthalazine | C8H6N2 – PubChem